Norman Pavelka

Dr. Norman Pavelka

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2010 in Nature
Verified
Journal Article
Open access
PDF file
NPNorman Pavelka
Norman Pavelka
GRGiulia Rancati
Giulia Rancati
JZJin Zhu
Jin Zhu
WBWilliam D. Bradford
William D. Bradford
ASAnita Saraf
Anita Saraf
RLRong Li
Rong Li
Aneuploidy, the presence of an abnormal number of chromosomes, has been associated with developmental defects and cancer, but also with adaptive evolution in experimental organisms. Recent studies raised doubts over whether aneuploidy affects gene expression at the proteome level or whether it can bring phenotypic variation and improved fitness over euploid counterparts. A profiling study of a large set of aneuploid yeast strains grown under a variety of conditions demonstrates that aneuploidy can affect both the transcriptome and the proteome, and generate significant phenotypic variation that can lead to fitness gains. Profiling of a large set of aneuploid yeast strains grown under a variety of conditions demonstrates that aneuploidy can affect both the transcriptome and the proteome and can generate significant phenotypic variation that could lead to fitness gains. Aneuploidy, referring here to genome contents characterized by abnormal numbers of chromosomes, has been associated with developmental defects, cancer and adaptive evolution in experimental organisms1,2,3,4,5,6,7,8,9. However, it remains unresolved how aneuploidy impacts gene expression and whether aneuploidy could directly bring about phenotypic variation and improved fitness over that of euploid counterparts. Here we show, using quantitative mass spectrometry-based proteomics and phenotypic profiling, that levels of protein expression in aneuploid yeast strains largely scale with chromosome copy numbers, following the same trend as that observed for the transcriptome, and that aneuploidy confers diverse phenotypes. We designed a novel scheme to generate, through random meiotic segregation, 38 stable and fully isogenic aneuploid yeast strains with distinct karyotypes and genome contents between 1N and 3N without involving any genetic selection. Through quantitative growth assays under various conditions or in the presence of a panel of chemotherapeutic or antifungal drugs, we found that some aneuploid strains grew significantly better than euploid control strains under conditions suboptimal for the latter. These results provide strong evidence that aneuploidy directly affects gene expression at both the transcriptome and proteome levels and can generate significant phenotypic variation that could bring about fitness gains under diverse conditions. Our findings suggest that the fitness ranking between euploid and aneuploid cells is dependent on context and karyotype, providing the basis for the notion that aneuploidy can directly underlie phenotypic evolution and cellular adaptation.

1 November 2016 in Cell
Verified
Journal Article
Closed access
RHRob ter Horst
Rob ter Horst
MJmartin Jaeger
martin Jaeger
SSSanne P. Smeekens
Sanne P. Smeekens
MOMarije Oosting
Marije Oosting
MSMorris A. Swertz
Morris A. Swertz
MNMihai G. Netea
Mihai G. Netea

1 September 2001 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
Francesca GranucciFrancesca Granucci
Francesca Granucci
CVCaterina Vizzardelli
Caterina Vizzardelli
NPNorman Pavelka
Norman Pavelka
SFSonia Feau
Sonia Feau
MPMaria Persico
Maria Persico
PRPaola Ricciardi-Castagnoli
Paola Ricciardi-Castagnoli

1 November 2008 in Cell
Verified
Journal Article
Closed access
GRGiulia Rancati
Giulia Rancati
NPNorman Pavelka
Norman Pavelka
BFBrian Fleharty
Brian Fleharty
ANAaron Noll
Aaron Noll
RTRhonda Trimble
Rhonda Trimble
RLRong Li
Rong Li

16 October 2017 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
GRGiulia Rancati
Giulia Rancati
JMJason Moffat
Jason Moffat
ATAthanasios Typas
Athanasios Typas
NPNorman Pavelka
Norman Pavelka

1 June 2021 in Cell
Verified
Journal Article
Open access
AMArchita Mishra
Archita Mishra
GLGhee Chuan Lai
Ghee Chuan Lai
LYLeong Jing Yao
Leong Jing Yao
TAThet Tun Aung
Thet Tun Aung
NSNoam Shental
Noam Shental
FGFlorent Ginhoux
Florent Ginhoux
The human fetal immune system begins to develop early during gestation; however, factors responsible for fetal immune-priming remain elusive. We explored potential exposure to microbial agents in utero and their contribution toward activation of memory T cells in fetal tissues. We profiled microbes across fetal organs using 16S rRNA gene sequencing and detected low but consistent microbial signal in fetal gut, skin, placenta, and lungs in the 2nd trimester of gestation. We identified several live bacterial strains including Staphylococcus and Lactobacillus in fetal tissues, which induced in vitro activation of memory T cells in fetal mesenteric lymph node, supporting the role of microbial exposure in fetal immune-priming. Finally, using SEM and RNA-ISH, we visualized discrete localization of bacteria-like structures and eubacterial-RNA within 14th weeks fetal gut lumen. These findings indicate selective presence of live microbes in fetal organs during the 2nd trimester of gestation and have broader implications toward the establishment of immune competency and priming before birth.